[go: up one dir, main page]

FI20040270A0 - Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases - Google Patents

Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases

Info

Publication number
FI20040270A0
FI20040270A0 FI20040270A FI20040270A FI20040270A0 FI 20040270 A0 FI20040270 A0 FI 20040270A0 FI 20040270 A FI20040270 A FI 20040270A FI 20040270 A FI20040270 A FI 20040270A FI 20040270 A0 FI20040270 A0 FI 20040270A0
Authority
FI
Finland
Prior art keywords
inhibitors
containing amine
alcohol derivatives
copper containing
derivatives useful
Prior art date
Application number
FI20040270A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Ferenc Fulop
Laszlo Lazar
Marjo Pihlavisto
Marta Palko
Auni Juhakoski
Anne Marjamaeki
David John Smith
Original Assignee
Biotie Therapies Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Oyj filed Critical Biotie Therapies Oyj
Priority to FI20040270A priority Critical patent/FI20040270A0/en
Publication of FI20040270A0 publication Critical patent/FI20040270A0/en
Priority to PCT/FI2005/050038 priority patent/WO2005080319A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/22—Hydrazines having nitrogen atoms of hydrazine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20040270A 2004-02-20 2004-02-20 Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases FI20040270A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20040270A FI20040270A0 (en) 2004-02-20 2004-02-20 Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases
PCT/FI2005/050038 WO2005080319A1 (en) 2004-02-20 2005-02-18 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20040270A FI20040270A0 (en) 2004-02-20 2004-02-20 Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases

Publications (1)

Publication Number Publication Date
FI20040270A0 true FI20040270A0 (en) 2004-02-20

Family

ID=31725746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040270A FI20040270A0 (en) 2004-02-20 2004-02-20 Hydrazino alcohol derivatives useful as inhibitors of copper containing amine oxidases

Country Status (2)

Country Link
FI (1) FI20040270A0 (en)
WO (1) WO2005080319A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004241060B2 (en) 2003-05-26 2009-07-23 Biotie Therapies Corp. Crystalline VAP-1 and uses thereof
TWI490214B (en) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
UA112154C2 (en) 2009-09-08 2016-08-10 Біоті Терапіс Корп. APPLICATION OF FULLY HUMAN ANTI-VAP-1-ANTIBODY FOR TREATMENT OF FIBROUS CONDITIONS
CA2915163A1 (en) 2013-06-12 2014-12-18 Proximagen Limited New therapeutic uses of enzyme inhibitors
ES2714125T3 (en) 2014-04-15 2019-05-27 Pecsi Tudomanyegyetem Semicarbazide-sensitive amino oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
WO2017098236A1 (en) 2015-12-07 2017-06-15 Proximagen Limited Vap-1 inhibitors for treating pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1450998A (en) * 2000-07-05 2003-10-22 拜奥泰治疗公司 Inhibitors of copper-containing amine oxidases
AU2004241060B2 (en) * 2003-05-26 2009-07-23 Biotie Therapies Corp. Crystalline VAP-1 and uses thereof

Also Published As

Publication number Publication date
WO2005080319A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
DK2039685T3 (en) Heterobicyclic Compounds as P38 Inhibitors
DK1789041T3 (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
SI1891973T1 (en) Combinations comprising antimuscarinic agents of PDE inhibitors
ATE505460T1 (en) INDAZOL DERIVATIVES AS INHIBITORS OF HORMONESENSITIVE LIPASE
IL180018A0 (en) Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
DK1664043T3 (en) Compositions suitable as inhibitors of protein kinases
DK1962830T3 (en) Azaindole inhibitors of aurorakinases.
DK1797042T3 (en) Indozolone derivatives as 11B-HSD1 inhibitors
DK1940839T3 (en) Pyridopyrimidione Inhibitors of P13Ka
ATE452631T1 (en) N-2-ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETAHYDROXYSTEROID DEHYDROGENASE INHIBITORS
DE602005025733D1 (en) PYRAZOLOPYRIMIDIN DERIVATIVES AS INHIBITORS OF CYCLINE-DEPENDENT KINASE
DK1713806T3 (en) Compounds and Compositions as Protein Kinase Inhibitors
DK1881976T3 (en) Substituted amide derivatives as protein kinase inhibitors
DK1948643T3 (en) 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
DK1944305T3 (en) Quinoline derivatives as phosphodiesterase inhibitors
DK2301544T3 (en) Quinoline derivatives as intermediates for mycobacterial inhibitors
DK1848694T3 (en) Heterocyclic substituted phenylmethanones as inhibitors of glycine transport
CY2014011I2 (en) ADMINISTRATION OF DIPEPTIDYLOPEPTIDASE INHIBITORS
SE0701538L (en) Azaspiroalkane derivatives as inhibitors of metalloproteases
DK1562589T3 (en) Diaminotriazoles useful as inhibitors of protein kinases
DK3305776T3 (en) PYRROL COMPOUNDS AS INHIBITORS OF ERK-PROTEIN KINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DK1981875T3 (en) SUBSTITUTED INDOLYLALKYLAMINODE DERIVATIVES AS INHIBITORS OF HISTONDEACETYLASE
ATE401893T1 (en) THIOPHENEPYRIMIDINONE AS 17-BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS
DK1811998T3 (en) Triazoles useful as inhibitors of protein kinases
DK1778686T3 (en) Triazolopyridinylsulfanyl derivatives as P38 MAP kinase inhibitors

Legal Events

Date Code Title Description
FD Application lapsed